DocMorris ( (CH:DOCM) ) just unveiled an announcement.
DocMorris AG’s shareholders have approved a capital increase through a rights issue to raise approximately CHF 200 million, aimed at financing growth in prescription drugs and achieving positive cash flow by 2027. The capital increase will also support marketing expenses and potentially repay a CHF 95 million convertible bond. The rights issue involves offering new shares to existing shareholders and eligible investors, with trading and settlement scheduled for May 2025.
More about DocMorris
DocMorris AG is a prominent player in the online pharmacy, marketplace, and professional healthcare sectors, with a strong presence in Germany and other European countries. The company operates a highly automated logistics center in the Netherlands and leads the health and care products marketplace in Southern Europe. With a vision to create a digital health ecosystem, DocMorris serves over 10 million active customers and achieved external sales of CHF 1,085 million in 2024.
Average Trading Volume: 136,633
Current Market Cap: CHF315.6M
See more data about DOCM stock on TipRanks’ Stock Analysis page.